ライフサイエンスコーパス: carotid artery stent

1 nt, and one patient underwent placement of a carotid artery stent.

2 ata outside of controlled clinical trials in carotid artery stenting.

3 lic Protection System in patients undergoing carotid artery stenting.

4 lirudin and unfractionated heparin (UFH) for carotid artery stenting.

5 ith UFH during the index hospitalization for carotid artery stenting.

6 re for long-term mortality in patients after carotid artery stenting.

7 ensively investigated in patients undergoing carotid artery stenting.

8 to 2 years after carotid endarterectomy and carotid artery stenting.

9 Carotid endarterectomy and carotid artery stenting.

10 dical treatment, carotid endarterectomy, and carotid artery stenting.

11 endarterectomy, and may be safely treated by carotid artery stenting.

12 darterectomy (2.26, 1.34-3.77) but not after carotid artery stenting (0.77, 0.41-1.42).

13 d had eligible ultrasonography (1086 who had carotid artery stenting, 1105 who had carotid endarterec

14 1036 patients (536 randomly allocated to carotid artery stenting, 500 to carotid endarterectomy)

15 Two independent cohorts after successful carotid artery stenting (602 and 552 patients) were pros

16 An additional 8 carotid artery stenting and 12 carotid endarterectomy pa

17 Among 2502 patients, 14 MIs occurred in carotid artery stenting and 28 MIs in carotid endarterec

18 (CREST) found a higher risk of stroke after carotid artery stenting and a higher risk of myocardial

19 ral stroke thereafter did not differ between carotid artery stenting and carotid endarterectomy for s

20 the primary endpoint did not differ between carotid artery stenting and carotid endarterectomy in pa

21 l data comparing carotid endarterectomy with carotid artery stenting and describe ischemic visual sym

22 Carotid-artery stenting and carotid endarterectomy are b

23 differ significantly in the group undergoing carotid-artery stenting and the group undergoing carotid

24 Carotid endarterectomy and carotid artery stenting are the leading approaches to re

25 lopidogrel and Atorvastatin Treatment During Carotid Artery Stenting [ARMYDA-9 CAROTID]; NCT01572623)

26 patients in the CARE Registry who underwent carotid artery stenting between May 2005 and March 2012

27 randomized to carotid endarterectomy versus carotid artery stenting, both MI and biomarker+ only wer

28 modynamic depression has been reported after carotid artery stenting CAS and carotid endarterectomy (

29 Carotid artery stent (CAS) placement offers a less invas

30 lict regarding the relative effectiveness of carotid artery stenting (CAS) and carotid artery endarte

31 four randomised controlled trials comparing carotid artery stenting (CAS) and carotid endarterectomy

32 ncreased risk of periprocedural stroke after carotid artery stenting (CAS) compared with carotid enda

33 Despite increased carotid artery stenting (CAS) dissemination following th

34 Carotid artery stenting (CAS) has achieved clinical equi

35 Carotid artery stenting (CAS) has become an alternative

36 ought to evaluate the safety and efficacy of carotid artery stenting (CAS) in high risk patients.

37 y was to evaluate the safety and efficacy of carotid artery stenting (CAS) in high-risk patients.

38 ding whether carotid endarterectomy (CEA) or carotid artery stenting (CAS) may be superior for stroke

39 h following carotid endarterectomy (CEA) and carotid artery stenting (CAS) on a national level in Ger

40 ndarterectomy (CEA) plus medical therapy, or carotid artery stenting (CAS) plus medical therapy for a

41 Effectiveness of carotid artery stenting (CAS) relative to carotid endart

42 Clinical trials demonstrated the efficacy of carotid artery stenting (CAS) relative to carotid endart

43 dicaid Services require hospitals performing carotid artery stenting (CAS) to recertify the quality o

44 fe (HRQOL) outcomes in patients treated with carotid artery stenting (CAS) versus carotid endarterect

45 esigned to assess the safety and efficacy of carotid artery stenting (CAS) when performed by physicia

46 as to evaluate the feasibility and safety of carotid artery stenting (CAS) with a filter protection s

47 ted imaging (DWI) are frequently found after carotid artery stenting (CAS), but their clinical releva

48 ts following carotid endarterectomy (CEA) or carotid artery stenting (CAS), the applicability of thes

49 risk factors for their development following carotid artery stenting (CAS).

50 A recent alternative is carotid artery stenting (CAS).

51 to predict in-hospital stroke or death after carotid artery stenting (CAS).

52 -protected versus proximal balloon-protected carotid artery stenting (CAS).

53 quences of hemodynamic depression (HD) after carotid artery stenting (CAS).

54 undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS); to describe hospital vari

55 1.41) and 31 (6.8%) of 455 women assigned to carotid artery stenting compared with 16 (3.8%) of 417 a

56 occurred in 35 (4.3%) of 807 men assigned to carotid artery stenting compared with 40 (4.9%) of 823 a

57 Rates of the primary endpoint for carotid artery stenting compared with carotid endarterec

58 ow-up is needed to establish the efficacy of carotid artery stenting compared with endarterectomy.

59 ural intervention (carotid endarterectomy or carotid artery stenting) compared with medical managemen

60 Carotid artery stenting, compared with carotid endartere

61 This study sought to report the effect of carotid artery stenting (CS) on neurocognitive function

62 Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1+/

63 The impact of carotid artery stent fractures on the incidence of adver

64 Participants in PMS studies for carotid artery stenting have different clinical and proc

65 g-term effectiveness in stroke prevention by carotid artery stenting in a large number of patients in

66 The role of carotid artery stenting in acute stroke, including its u

67 ed from controlled clinical trials undergoes carotid artery stenting in daily clinical practice.

68 ggest that independent modular filter use in carotid artery stenting in high surgical risk patients i

69 nrandomized, open-label, single-arm study of carotid artery stenting in high surgical risk patients w

70 To evaluate outcomes after carotid artery stenting in larger real-world populations

71 es, and subsequent all-cause mortality after carotid artery stenting in PMS study participants and no

72 Whether PMS studies are representative of carotid artery stenting in routine clinical practice has

73 eview outcomes of carotid endarterectomy and carotid artery stenting in women, discuss differences in

74 rom 1999 to 2014, whereas the performance of carotid artery stenting increased until 2006 and then de

75 Carotid artery stenting is an alternative option in pati

76 Long-term stroke prevention by carotid artery stenting is effective in experienced cent

77 Carotid artery stenting is feasible, can be performed ev

78 r, the role of direct thrombin inhibitors in carotid artery stenting is not well defined.

79 In 2 years, 58 patients who underwent carotid artery stenting (Kaplan-Meier rate 6.0%) and 62

80 Carotid artery stenting may be a reasonable alternative,

81 75.8 years; 43% women) and 231077 underwent carotid artery stenting (mean age, 75.4 years; 49% women

82 signed to carotid endarterectomy (n=1240) or carotid artery stenting (n=1262), 872 (34.9%) of whom we

83 US successfully depicted carotid artery stent occlusion and a moderate stent coll

84 carotid artery stenosis randomly assigned to carotid artery stenting or carotid endarterectomy (Abbot

85 dy (ICSS) were randomly allocated to receive carotid artery stenting or carotid endarterectomy.

86 randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy.

87 or asymptomatic carotid stenosis to undergo carotid-artery stenting or carotid endarterectomy.

88 e determined with randomized trials in which carotid artery stent placement is directly compared with

89 cription of the current technical aspects of carotid artery stent placement is presented.

90 ient-specific simulated rehearsal (PsR) of a carotid artery stenting procedure (CAS) enables the inte

91 Embolic protection during carotid artery stenting reduces the rate of thromboembol

92 Carotid artery stenting should be avoided in patients wi

93 ve shown a higher early risk of stroke after carotid artery stenting than after carotid endarterectom

94 Stroke occurs more commonly after carotid artery stenting than after carotid endarterectom

95 events seems to be higher in women who have carotid artery stenting than those who have carotid enda

96 In patients treated with carotid artery stenting, those with an ARWMC score of 7

97 Extrapolating results from PMS studies of carotid artery stenting to larger real-world settings sh

98 tive risk of stroke in patients treated with carotid artery stenting versus carotid endarterectomy.

99 Carotid artery stenting was associated with a higher ris

100 Carotid artery stenting was performed with the Protege S

101 of this study was to determine the safety of carotid artery stenting with a unique distal embolic pro

102 term outcomes between patients who underwent carotid artery stenting with an emboli-protection device

103 gh-risk features for carotid endarterectomy, carotid artery stenting with distal embolic protection i

104 (Carotid Artery Stenting With Emboli Protection Surveilla

105 The CASES-PMS (Carotid Artery Stenting With Emboli Protection Surveilla

106 Carotid artery stenting with filter protection is techni

107 We compared the safety of carotid artery stenting with that of carotid endarterect

108 The trial evaluated carotid artery stenting with the use of an emboli-protec

109 Previous clinical trials have suggested that carotid-artery stenting with a device to capture and rem

110 in 20 patients randomly assigned to undergo carotid-artery stenting with an emboli-protection device

111 In this trial, we compared carotid-artery stenting with embolic protection and caro

112 We conducted a randomized trial comparing carotid-artery stenting with the use of an emboli-protec